Key result
Curcumin inhibits TGF-β-driven inflammatory cytokines, Smad2L phosphorylation, and ROS production in human VSMCs.
Answers are grounded in this paper and cite their sources.
Transforming growth factor-β (TGF-β) induces pro-inflammatory cytokines expression including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) and these cytokines are associated with the development of atherosclerosis. Curcumin has anti-atherogenic effects and anti-inflammatory properties in the vascular wall, but the relative mechanisms are almost unknown. In the present study, we investigate the effect of curcumin on modulating the pro-inflammatory action of TGF-β in human vascular smooth muscle cells (VSMCs) and its molecular mechanisms. Cultured VSMCs were seeded into several groups: a control group (untreated group), a group treated with TGF-β, and several groups treated with TGF-β plus inhibitors. The cells were pre-treated with diphenyleneiodonium chloride, DPI, (20 μM), curcumin (5, 10 and 20 μM) and N-Acetyl-L-Cysteine, NAC, (10 mM) and then TGF-β (5 ng/mL) was added to the culture medium. The mRNA levels of IL-6 and TNF-α were detected by quantitative Real-Time Polymerase Chain Reaction. For monitoring the Smad2 linker region phosphorylation (pSmad2L), the western-blotting technique was applied and reactive oxygen species (ROS) generation was measured by utilizing 2',7'-dichlorofluorescein diacetate-based assay. TGF-β increased the mRNA expression of IL-6 (p=0.02 and p=0.001) and TNF-α (p =0.014 and p = 0.001) in a time-dependent manner, ROS production (p=0.03) and Smad2L phosphorylation (p=0.015). Pre-treatment with curcumin, DPI and NAC inhibited TGF-β-induced IL-6 (p=0.04) and TNF-α (p=0.001) mRNA expression, Smad2L phosphorylation (p=0.02) and ROS production (0.03). Pharmacological inhibition by Curcumin blocks TGF-β-induced ROS production, Smad2L phosphorylation, and IL-6 and TNF-α mRNA expression in human VSMCs.
No takes yet. Share an insight, caveat, or question.
Asadi et al. (2020) studied Atherosclerosis (in vitro human vascular smooth muscle cells). Curcumin (with DPI and NAC as comparator inhibitors) vs. Untreated control and TGF-β (5 ng/mL) alone was evaluated on TGF-β-induced IL-6 and TNF-α mRNA expression, Smad2L phosphorylation, and ROS production (p=0.04 (IL-6), 0.001 (TNF-α), 0.02 (pSmad2L), 0.03 (ROS)). Pre-treatment with curcumin inhibited TGF-β-induced IL-6 and TNF-α mRNA expression, Smad2L phosphorylation, and ROS production in human VSMCs.
Synapse has enriched 10 related papers. Consider them for comparative context: